Allverm 4% Oral Suspension for Sheep

Država: Velika Britanija

Jezik: engleski

Izvor: VMD (Veterinary Medicines Directorate)

Aktivni sastojci:

Albendazole Oxide

Dostupno od:

Novartis Animal Health UK Ltd

ATC koda:

QP52AC11

INN (International ime):

Albendazole Oxide

Farmaceutski oblik:

Oral suspension

Tip recepta:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

Terapijska grupa:

Sheep

Područje terapije:

Anthelmintic trace element

Status autorizacije:

Expired

Datum autorizacije:

1990-01-18

Svojstava lijeka

Revised: 23 June 2010
AN: 00376/2010
1
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Allverm 4% Oral Suspension for sheep
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Substance
% w/v
_Albendazole oxide (ricobendazole)_
_4.00_
Other ingredients
Cobalt sulphate (heptahydrate)
2.88
[equivalent to 0.377% w/v elemental cobalt]
Sodium selenate (anhydrous)
0.154
[equivalent to 0.041% w/v elemental selenium]
Antimicrobial preservatives:
Methyl parahydroxybenzoate 0.15
Propyl parahydroxybenzoate
0.015
Sodium Metabisulphate
0.10
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Oral suspension
A pink coloured aqueous oral suspension
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Sheep
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Broad spectrum worm and fluke drench;
For the control of adult and larval stages of benzimidazole-sensitive
gastro-
intestinal roundworms (_Bunostomum, Chabertia, Cooperia, Haemonchus, _
_Nematodirus, Oesophagostomum, Ostertagia, Strongyloides _and_ _
_Trichostrongylus_), tapeworms (_Moniezia_) and lungworms
(_Dictyocaulus_ _filaria_),
and for the control of adult liver fluke _(Fasciola hepatica)_ and the
treatment of
chronic, but not acute, fascioliasis in sheep
Ovicidal to round worm eggs
Also aids in the prevention of cobalt and selenium deficiency.
Revised: 23 June 2010
AN: 00376/2010
2
4.3
CONTRAINDICATIONS
Ewes should not be treated at the fluke and worm dose during tupping
and until
one month after the tups are removed.
Not recommended for use in cattle.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Care should be taken to avoid the following practices because they
increase the
risk of development of resistance and could ultimately result in
ineffective therapy:
Too frequent and repeated use of anthelmintics from the same class,
over an
extended period of time
Under dosing, which may be due to underestimation of body weight,
misadministration of the product, or lack of calibration of the dosing
device (if any)
Suspected clinica